SEC
SlamSEC
Search
Browse
Earnings
OKYO Pharma Ltd
Nasdaq:
OKYO
Biological Products, (No Diagnostic Substances)
·
LONDON, X0
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Governance
proxy statements · beneficial ownership
Ownership Filings
13 shown
Filed
Form
Description
10/31/23
4
4
→
9/28/23
4
4
→
5/20/22
4
4
→
5/19/22
4
4
→
5/19/22
4
4
→
5/18/22
4/A
4/A
→
↓
CEO
Jacob Gary S